WHO MAKES THE DIABETES DRUG COPYRIGHT NO FURTHER A MYSTERY

Novo Nordisk's pricing techniques in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of selling price gouging, declaring the stark distinction concerning U.S. charges and those in Europe and copyright.In Oct 2024, Novo Nordisk revealed a research on scientific journal Character about a novel glu